Sun Pharma could drop Ranbaxy name, sources say

04/9/2014 | Reuters · Times of India, The

Sources say Sun Pharmaceutical Industries, which announced Monday that it is taking over Ranbaxy Laboratories, could phase out the Ranbaxy brand of generic drugs by the end of the year over quality issues. Sun Pharma's senior vice president of finance and accounts, Uday Baldota, said the Ranbaxy brand "has a value" and will be used and preserved. Pharmaceutical and branding experts called Ranbaxy a "damaged brand" and said it would be best for Sun to drop it. Sun Pharma officials said their biggest priority is bringing Ranbaxy's four manufacturing firms in India into compliance with U.S. FDA standards.

View Full Article in:

Reuters · Times of India, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA